BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29853808)

  • 1. Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide.
    Caillé F; Goutal S; Marie S; Auvity S; Cisternino S; Kuhnast B; Pottier G; Tournier N
    Contrast Media Mol Imaging; 2018; 2018():7310146. PubMed ID: 29853808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of P-glycoprotein on pulmonary disposition of the model substrate [
    Mairinger S; Hernández-Lozano I; Filip T; Löbsch M; Stanek J; Zeitlinger M; Hacker M; Tournier N; Wanek T; Ehrhardt C; Langer O
    Eur J Pharm Sci; 2023 Apr; 183():106404. PubMed ID: 36773747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide.
    Pottier G; Marie S; Goutal S; Auvity S; Peyronneau MA; Stute S; Boisgard R; Dollé F; Buvat I; Caillé F; Tournier N
    J Nucl Med; 2016 Feb; 57(2):309-14. PubMed ID: 26585058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of
    Auvity S; Caillé F; Marie S; Wimberley C; Bauer M; Langer O; Buvat I; Goutal S; Tournier N
    J Nucl Med; 2018 Oct; 59(10):1609-1615. PubMed ID: 29748235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.
    Damont A; Goutal S; Auvity S; Valette H; Kuhnast B; Saba W; Tournier N
    Eur J Pharm Sci; 2016 Aug; 91():98-104. PubMed ID: 27283486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric Imaging of P-Glycoprotein Function at the Blood-Brain Barrier Using k
    Breuil L; El Biali M; Vodovar D; Marie S; Auvity S; Bauer M; Goutal S; Rodrigo S; Langer O; Tournier N
    Mol Imaging Biol; 2023 Dec; 25(6):1135-1141. PubMed ID: 37801196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function.
    Goutal S; Novell A; Leterrier S; Breuil L; Selingue E; Gerstenmayer M; Marie S; Saubaméa B; Caillé F; Langer O; Truillet C; Larrat B; Tournier N
    J Control Release; 2023 Sep; 361():483-492. PubMed ID: 37562557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
    Kreisl WC; Bhatia R; Morse CL; Woock AE; Zoghbi SS; Shetty HU; Pike VW; Innis RB
    J Nucl Med; 2015 Jan; 56(1):82-7. PubMed ID: 25500831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and Sensitivity of [
    Hernández-Lozano I; Leterrier S; Mairinger S; Stanek J; Zacher AS; Breyer L; Hacker M; Zeitlinger M; Pahnke J; Tournier N; Wanek T; Langer O
    Mol Pharm; 2024 Feb; 21(2):932-943. PubMed ID: 38225758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate
    Tournier N; Bauer M; Pichler V; Nics L; Klebermass EM; Bamminger K; Matzneller P; Weber M; Karch R; Caillé F; Auvity S; Marie S; Jäger W; Wadsak W; Hacker M; Zeitlinger M; Langer O
    J Nucl Med; 2019 Jul; 60(7):985-991. PubMed ID: 30630940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?
    Breuil L; Marie S; Goutal S; Auvity S; Truillet C; Saba W; Langer O; Caillé F; Tournier N
    J Cereb Blood Flow Metab; 2022 Jan; 42(1):175-185. PubMed ID: 34496661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Mairinger S; Leterrier S; Filip T; Löbsch M; Pahnke J; Hernández-Lozano I; Stanek J; Tournier N; Zeitlinger M; Hacker M; Langer O; Wanek T
    J Cereb Blood Flow Metab; 2024 Jan; 44(1):142-152. PubMed ID: 37728771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate.
    Eyal S; Chung FS; Muzi M; Link JM; Mankoff DA; Kaddoumi A; O'Sullivan F; Hebert MF; Unadkat JD
    J Nucl Med; 2009 May; 50(5):798-806. PubMed ID: 19403878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Blood-Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug-Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging.
    Breuil L; Goutal S; Marie S; Del Vecchio A; Audisio D; Soyer A; Goislard M; Saba W; Tournier N; Caillé F
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [¹¹C]Rhodamine-123: synthesis and biodistribution in rodents.
    Bao X; Lu S; Liow JS; Morse CL; Anderson KB; Zoghbi SS; Innis RB; Pike VW
    Nucl Med Biol; 2012 Nov; 39(8):1128-36. PubMed ID: 22898316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (R)-[¹¹C]Emopamil as a novel tracer for imaging enhanced P-glycoprotein function.
    Toyohara J; Okamoto M; Aramaki H; Zaitsu Y; Shimizu I; Ishiwata K
    Nucl Med Biol; 2016 Jan; 43(1):52-62. PubMed ID: 26429767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.
    Bauer M; Bamminger K; Pichler V; Weber M; Binder S; Maier-Salamon A; Tahir A; Jäger W; Haslacher H; Tournier N; Hacker M; Zeitlinger M; Langer O
    Clin Pharmacol Ther; 2021 Mar; 109(3):754-761. PubMed ID: 32966590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide.
    Farwell MD; Chong DJ; Iida Y; Bae SA; Easwaramoorthy B; Ichise M
    Ann Nucl Med; 2013 Aug; 27(7):618-24. PubMed ID: 23572210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein overactivity in epileptogenic developmental lesions measured in vivo using (R)-[
    Ilyas-Feldmann M; Asselin MC; Wang S; McMahon A; Anton-Rodriguez J; Brown G; Hinz R; Duncan JS; Sisodiya SM; Koepp M
    Epilepsia; 2020 Jul; 61(7):1472-1480. PubMed ID: 32627849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.